No Data
JonesTrading Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Maintains Target Price $32
OnKure Therapeutics Initiated at Buy by Jones Trading
JonesTrading Initiates OnKure Therapeutics(OKUR.US) With Buy Rating, Announces Target Price $32
12 Health Care Stocks Moving In Friday's Pre-Market Session
Express News | Watching OnKure Therapeutics; Shares See Volume As Traders Circulate Stock Moving In Sympathy With Eli Lilly's Acquisition Talks To Buy Scorpion Therapeutics; Co Developing Mutant-Selective PI3Kα Inhibitors
Oppenheimer Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Maintains Target Price $35
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
